Cellumed Co Ltd
KOSDAQ:049180
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Cellumed Co Ltd (049180) under the Base Case is 1 105.52 KRW per share. Compared with the current market price of 1 009 KRW, the stock appears Undervalued by 9% .
The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 3% a year over the next five years, less than half its five-year pace of 9%. If revenue grew at its five-year pace of 9%, the estimate would be about ₩1,293. The forecast years subtract value, so the estimate rests entirely on the years after 2031.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Cellumed Does
CELLUMED Co., Ltd. engages in the manufacture and distribution of medical device and biomaterials. The company is headquartered in Seoul, Seoul. The company went IPO on 2002-05-23. The Company’s products consist of allografts for tissue repair; bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration; biosimilars, such as bone morphogenetic protein 2 (BMP2) reagents and others, as well as medical devices, such as spinal fixation systems, joint replacements and navigation systems. The firm sells its products within domestic market and to overseas markets.
- Headquarters
- Korea KR
- IPO date
- May 23, 2002
Revenue & Expenses Breakdown
Cellumed Co Ltd
Earnings Waterfall
Cellumed Co Ltd
Continue Research
Decided on Cellumed? Get an email when Cellumed Co Ltd reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one Cellumed Co Ltd stock?
The intrinsic value for Cellumed Co Ltd (049180) under the Base Case is 1 105.52 KRW.
Is Cellumed Co Ltd stock undervalued or overvalued?
Compared with the current market price of 1 009 KRW, the stock appears Undervalued by 9% .